A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions

被引:369
作者
Pérez-Moreno, MA
Locascio, A
Rodrigo, I
Dhondt, G
Portillo, F
Nieto, MA
Cano, A
机构
[1] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain
[2] CSIC, Inst Cajal, E-28002 Madrid, Spain
关键词
D O I
10.1074/jbc.M100827200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Down-regulation of E-cadherin expression is a determinant of tumor cell invasiveness, an event frequently associated with epithelial-mesenchymal transitions. Here we show that the mouse E12/E47 basic helix-loop-helix transcription factor (the E2A gene product) acts as a repressor of E-cadherin expression and triggers epithelial-mesenchymal transitions. The mouse E47 factor was isolated in a one-hybrid system designed to isolate repressors of the mouse E-cadherin promoter. Epithelial cells ectopically expressing E47 adopt a fibroblastic phenotype and acquire tumorigenic and migratory/invasive properties, concomitant with the suppression of E-cadherin expression. Suppression of E-cadherin expression under stable or inducible expression of E47 in epithelial cells occurs at the transcriptional level and is dependent on the E-boxes of the E-cadherin promoter. Interestingly, analysis of endogenous E2A expression in murine and human cell lines illustrated its presence in E-cadherin-deficient, invasive carcinoma cells but its absence from epithelial cell lines. This expression pattern is consistent with that observed in early mouse embryos, where E2A mRNA is absent from epithelia but strongly expressed in the mesoderm. These results implicate E12/E47 as a repressor of E-cadherin expression during both development and tumor progression and indicate its involvement in the acquisition and/or maintenance of the mesenchymal phenotype.
引用
收藏
页码:27424 / 27431
页数:8
相关论文
共 57 条
  • [1] THE E2A GENE-PRODUCT CONTAINS 2 SEPARABLE AND FUNCTIONALLY DISTINCT TRANSCRIPTION ACTIVATION DOMAINS
    ARONHEIM, A
    SHIRAN, R
    ROSEN, A
    WALKER, MD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) : 8063 - 8067
  • [2] CELL-SPECIFIC EXPRESSION OF HELIX-LOOP-HELIX TRANSCRIPTION FACTORS ENCODED BY THE E2A GENE
    ARONHEIM, A
    SHIRAN, R
    ROSEN, A
    WALKER, MD
    [J]. NUCLEIC ACIDS RESEARCH, 1993, 21 (07) : 1601 - 1606
  • [3] E2A PROTEINS ARE REQUIRED FOR PROPER B-CELL DEVELOPMENT AND INITIATION OF IMMUNOGLOBULIN GENE REARRANGEMENTS
    BAIN, G
    MAANDAG, ECR
    IZON, DJ
    AMSEN, D
    KRUISBEEK, AM
    WEINTRAUB, BC
    KROP, I
    SCHLISSEL, MS
    FEENEY, AJ
    VANROON, M
    VANDERVALK, M
    TERIELE, HPJ
    BERNS, A
    MURRE, C
    [J]. CELL, 1994, 79 (05) : 885 - 892
  • [4] The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
    Batlle, E
    Sancho, E
    Franci, C
    Domínguez, D
    Monfar, M
    Baulida, J
    de Herreros, AG
    [J]. NATURE CELL BIOLOGY, 2000, 2 (02) : 84 - 89
  • [5] THE E-CADHERIN PROMOTER - FUNCTIONAL-ANALYSIS OF A G.C-RICH REGION AND AN EPITHELIAL CELL-SPECIFIC PALINDROMIC REGULATORY ELEMENT
    BEHRENS, J
    LOWRICK, O
    KLEINHITPASS, L
    BIRCHMEIER, W
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) : 11495 - 11499
  • [6] Behrens J, 1992, Semin Cell Biol, V3, P169
  • [7] Bellairs R., 1987, P123
  • [8] THE PROTEIN ID - A NEGATIVE REGULATOR OF HELIX-LOOP-HELIX DNA-BINDING PROTEINS
    BENEZRA, R
    DAVIS, RL
    LOCKSHON, D
    TURNER, DL
    WEINTRAUB, H
    [J]. CELL, 1990, 61 (01) : 49 - 59
  • [9] E-cadherin is a tumour invasion suppressor gene mutated in human lobular breast cancers
    Berx, G
    CletonJansen, AM
    Nollet, F
    deLeeuw, WJF
    vandeVijver, MJ
    Cornelisse, C
    vanRoy, F
    [J]. EMBO JOURNAL, 1995, 14 (24) : 6107 - 6115
  • [10] CADHERIN EXPRESSION IN CARCINOMAS - ROLE IN THE FORMATION OF CELL-JUNCTIONS AND THE PREVENTION OF INVASIVENESS
    BIRCHMEIER, W
    BEHRENS, J
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (01): : 11 - 26